ES2182840T3 - Factor xiii para el tratamiento de heridas de la piel. - Google Patents

Factor xiii para el tratamiento de heridas de la piel.

Info

Publication number
ES2182840T3
ES2182840T3 ES94908476T ES94908476T ES2182840T3 ES 2182840 T3 ES2182840 T3 ES 2182840T3 ES 94908476 T ES94908476 T ES 94908476T ES 94908476 T ES94908476 T ES 94908476T ES 2182840 T3 ES2182840 T3 ES 2182840T3
Authority
ES
Spain
Prior art keywords
factor xiii
treatment
skin wounds
skin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94908476T
Other languages
English (en)
Inventor
Naoko Kato
Takashi Ogawa
Shuji Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Application granted granted Critical
Publication of ES2182840T3 publication Critical patent/ES2182840T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UNA PREPARACION DERMICA PARA EL TRATAMIENTO DE HERIDAS EN LA PIEL QUE CONTIENE COMO INGREDIENTE ACTIVO UN FACTOR XIII DE COAGULACION DE LA SANGRE HUMANA. ESTA PREPARACION PUEDE CONTENER ADEMAS APROTININA. LA PREPARACION DERMICA, CUANDO SE APLICA A LA PIEL DAÑADA, ESPECIALMENTE A LA PIEL QUEMADA O ESCALDADA, PUEDE EJERCER UN SUMINISTRO SUPERIOR DEL INGREDIENTE ACTIVO, EL FACTOR XIII DE COAGULACION DE LA SANGRE HUMANA, AL TEJIDO AFECTADO, EN COMPARACION A LA ADMINISTRACION INTRAVENOSA Y SE PUEDE ADMINISTRAR SIN LA AYUDA DE UN MEDICO.
ES94908476T 1993-03-30 1994-03-02 Factor xiii para el tratamiento de heridas de la piel. Expired - Lifetime ES2182840T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7139593 1993-03-30

Publications (1)

Publication Number Publication Date
ES2182840T3 true ES2182840T3 (es) 2003-03-16

Family

ID=13459291

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94908476T Expired - Lifetime ES2182840T3 (es) 1993-03-30 1994-03-02 Factor xiii para el tratamiento de heridas de la piel.

Country Status (7)

Country Link
EP (1) EP0691850B1 (es)
KR (1) KR100302935B1 (es)
AT (1) ATE224727T1 (es)
AU (1) AU674061B2 (es)
DE (1) DE69431430T2 (es)
ES (1) ES2182840T3 (es)
WO (1) WO1994022470A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002172A1 (en) 1992-07-24 1994-02-03 Oklahoma Medical Research Foundation Blockade of protein c activation reduces microvascular surgical blood loss
IL125983A0 (en) * 1998-08-30 1999-04-11 Yeda Res & Dev Pharmaceutical composition comprising factor xiiia
IL161189A0 (en) 2001-10-09 2004-08-31 Zymogenetics Inc Method for inhibiting the formation of seromas using factor xiii
WO2003094937A1 (en) 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
JP2004075661A (ja) * 2002-06-18 2004-03-11 Shiseido Co Ltd 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法
EP1566183A1 (en) * 2004-02-20 2005-08-24 ZLB Behring GmbH Use of factor XIII for stimulating the perfusion of ischemic tissue
US10391062B2 (en) 2008-04-21 2019-08-27 Novo Nordisk Healthcare Ag Dry transglutaminase composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
ATE121776T1 (de) * 1986-09-19 1995-05-15 Zymogenetics Inc Expression des biologisch aktiven faktors xiii.
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
DE69431430D1 (de) 2002-10-31
ATE224727T1 (de) 2002-10-15
WO1994022470A1 (en) 1994-10-13
KR100302935B1 (ko) 2001-11-30
EP0691850B1 (en) 2002-09-25
DE69431430T2 (de) 2003-05-22
AU6155794A (en) 1994-10-24
AU674061B2 (en) 1996-12-05
KR960701657A (ko) 1996-03-28
EP0691850A1 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
US3777016A (en) Composition and method for the treat-ment of damaged skin
ATE363283T1 (de) Terfenadin-carboxylat und die behandlung von hautreizung
PT913156E (pt) Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
IL139231A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
US5525335A (en) Wound healing agent
WO2002060410A3 (en) Methods for sustained release local delivery of drugs for ablation of unwanted tissue
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
CA2064039A1 (en) Treatment to reduce edema for brain and musculature injuries
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
AU3401093A (en) Therapeutic agent for threatened abortion
AU5643299A (en) Humic acid and its use in the treatment of various conditions
DE69921678D1 (de) Zusammensetzung enthaltend di- und trinatriumsalze von echinochrome zur behandlung von augenerkrankungen
ES2312421T3 (es) Composicion farmaceutica en gel.
BR0104586A (pt) Método para tratamento de neurodegeneração
Spigel Opportunistic cutaneous myiasis
CA2159609A1 (en) Factor xiii for treatment of skin wounds
GEP20032906B (en) Controlled Release Peroral Pharmaceutical Composition of Levosimendan for Treatment of Congestive Heart Failure
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
Prescott Doxil offers hope to KS sufferers
RU2003344C1 (ru) Способ лечени ожоговой болезни
CA2336773A1 (en) Component b as angiogenic agent in combination with human growth factors
US20190209639A1 (en) Ointment for burn
OWNES Surgical treatment of burns: Use of pressure dressings